Albemarle Corporation
Albemarle Corporation (0HC7.L) Financial Performance & Income Statement Overview
Explore the financials of Albemarle Corporation (0HC7.L), including yearly and quarterly data on income, cash flow, and balance sheets.
Albemarle Corporation (0HC7.L) Income Statement & Financial Overview
Analyze Albemarle Corporation’s 0HC7.L earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.08B | $1.23B | $1.35B | $1.43B |
| Cost of Revenue | $920.58M | $1.09B | $1.46B | $1.44B |
| Gross Profit | $156.30M | $138.21M | -$104.03M | -$10.58M |
| Gross Profit Ratio | $0.15 | $0.11 | -$0.08 | -$0.007 |
| R&D Expenses | $14.10M | $20.02M | $22.40M | $20.77M |
| SG&A Expenses | $123.50M | $147.55M | $154.25M | $159.74M |
| Operating Expenses | $136.54M | $133.81M | $1.005B | $180.51M |
| Total Costs & Expenses | $1.06B | $1.26B | $2.46B | $1.62B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $44.70M | $47.76M | $35.19M |
| Depreciation & Amortization | $161.75M | $163.11M | $163.50M | $138.28M |
| EBITDA | $191.76M | $284.54M | -$967.58M | -$320.67M |
| EBITDA Ratio | $0.18 | $0.23 | -$0.71 | -$0.22 |
| Operating Income | $19.76M | $4.40M | -$1.11B | -$191.09M |
| Operating Income Ratio | $0.02 | $0.004 | -$0.82 | -$0.13 |
| Other Income/Expenses (Net) | -$38.73M | $72.33M | -$70.02M | -$1.52M |
| Income Before Tax | -$18.97M | $76.73M | -$1.18B | -$494.13M |
| Income Before Tax Ratio | -$0.02 | $0.06 | -$0.87 | -$0.35 |
| Income Tax Expense | -$18.63M | $10.61M | $110.85M | -$30.66M |
| Net Income | $41.35M | $75.29M | -$1.07B | -$188.20M |
| Net Income Ratio | $0.04 | $0.06 | -$0.79 | -$0.13 |
| EPS | -$0.003 | $0.29 | -$9.45 | -$1.60 |
| Diluted EPS | -$0.003 | $0.29 | -$9.45 | -$1.60 |
| Weighted Avg Shares Outstanding | $117.60M | $117.55M | $117.53M | $117.53M |
| Weighted Avg Shares Outstanding (Diluted) | $117.60M | $117.72M | $117.53M | $117.53M |
Over the last four quarters, Albemarle Corporation's revenue moved from $1.43B in Q2 2024 to $1.08B in Q1 2025. Operating income in Q1 2025 was $19.76M, with a strong operating margin of 2%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Albemarle Corporation remained robust at $191.76M, reflecting operational efficiency. Net income dropped to $41.35M, with an EPS of -$0.003. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan